I. A. Nikitina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
I. A. Nikitina has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr V. Leontiev
Moscow Clinical Scientific Center named after Loginov MHD; Moscow Financial and Industrial University “Synergy
2 shared publications - Anatoly I. Khavkin
Research Clinical Institute of Childhood; Belgorod State National Research University
2 shared publications - M. A. Orlyuk
SYNERGY University
2 shared publications - Andrey N. Surkov
Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
1 shared publication - E. O. Grozina
Moscow Clinical Scientific Center named after Loginov MHD
1 shared publication - Ekaterina Yablokova
Department of Children’s Diseases, N.F. Filatov Clinical Institute of Children’s Health, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 135-141
Cellular technologies in proctology
Modern regenerative surgery is a promising interdisciplinary field based on the use of stem cells and fully functional tissue equivalents created through cellular engineering techniques. These cells can differentiate into specialized cell types and modulate inflammatory processes, offering broad potential for the repair of damaged tissues. Of particular interest are multipotent mesenchymal stromal cells (MSCs), which exhibit high plasticity. They can differentiate into various cell lineages, including adipogenic, chondrogenic, osteogenic, and myogenic, as well as pancreatic cells, hepatocytes, and neural cells. Another key tool in regenerative medicine is platelet-rich plasma (PRP). Its advantages include ease of preparation and a minimal risk of immune reactions.
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 135-141
Open AccessCellular technologies in proctology
Modern regenerative surgery is a promising interdisciplinary field based on the use of stem cells and fully functional tissue equivalents created through cellular engineering techniques. These cells can differentiate into specialized cell types and modulate inflammatory processes, offering broad potential for the repair of damaged tissues. Of particular interest are multipotent mesenchymal stromal cells (MSCs), which exhibit high plasticity. They can differentiate into various cell lineages, including adipogenic, chondrogenic, osteogenic, and myogenic, as well as pancreatic cells, hepatocytes, and neural cells. Another key tool in regenerative medicine is platelet-rich plasma (PRP). Its advantages include ease of preparation and a minimal risk of immune reactions.
- Open Access
- 31 August 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 2,p. 187-193
Treatment of perianal manifestations of Crohn's disease
Currently, the treatment of patients with perianal manifestations of Crohn's disease is a complex task that requires an integrated approach. Existing methods of surgical correction are often only temporary, the rate of relapse of the disease remains high. Unsatisfactory treatment results, especially in the late postoperative period, a small number of clinical observations in published scientific papers devoted to the treatment of perianal fistulas against the background of Crohn's disease, the lack of a unified treatment strategy for these patients, as well as the low reliability of the results, determine the need for further research.
- 31 August 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 2,p. 187-193
Open AccessTreatment of perianal manifestations of Crohn's disease
Currently, the treatment of patients with perianal manifestations of Crohn's disease is a complex task that requires an integrated approach. Existing methods of surgical correction are often only temporary, the rate of relapse of the disease remains high. Unsatisfactory treatment results, especially in the late postoperative period, a small number of clinical observations in published scientific papers devoted to the treatment of perianal fistulas against the background of Crohn's disease, the lack of a unified treatment strategy for these patients, as well as the low reliability of the results, determine the need for further research.